LT2580226T - Trisacharidų dariniai ir jų, kaip adjuvantų, panaudojimas - Google Patents

Trisacharidų dariniai ir jų, kaip adjuvantų, panaudojimas

Info

Publication number
LT2580226T
LT2580226T LTEP11725217.1T LT11725217T LT2580226T LT 2580226 T LT2580226 T LT 2580226T LT 11725217 T LT11725217 T LT 11725217T LT 2580226 T LT2580226 T LT 2580226T
Authority
LT
Lithuania
Prior art keywords
adjuvants
trisaccharide derivates
trisaccharide
derivates
Prior art date
Application number
LTEP11725217.1T
Other languages
English (en)
Lithuanian (lt)
Inventor
Johannes Gernardus Mathias Marie Van Bree
Everardus Joannes Peter Maria Schenkelaars
Jouwert Anne Turkstra
Maria Aldegonda Jacoba Kriek
Robert Patrick Hof
Wilhelmus Martinus Maria Schaaper
Original Assignee
Immunovo B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovo B.V. filed Critical Immunovo B.V.
Publication of LT2580226T publication Critical patent/LT2580226T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
LTEP11725217.1T 2010-06-11 2011-06-03 Trisacharidų dariniai ir jų, kaip adjuvantų, panaudojimas LT2580226T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10165707A EP2397484A1 (en) 2010-06-11 2010-06-11 Trisaccharide derivates, and their use as adjuvants
PCT/NL2011/050393 WO2011155822A1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants

Publications (1)

Publication Number Publication Date
LT2580226T true LT2580226T (lt) 2018-02-26

Family

ID=43734127

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP11725217.1T LT2580226T (lt) 2010-06-11 2011-06-03 Trisacharidų dariniai ir jų, kaip adjuvantų, panaudojimas

Country Status (25)

Country Link
US (2) US9327020B2 (cg-RX-API-DMAC7.html)
EP (3) EP2397484A1 (cg-RX-API-DMAC7.html)
JP (2) JP6004586B2 (cg-RX-API-DMAC7.html)
KR (1) KR101929973B1 (cg-RX-API-DMAC7.html)
CN (1) CN103154013B (cg-RX-API-DMAC7.html)
AU (1) AU2011262606B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012031440A2 (cg-RX-API-DMAC7.html)
CA (1) CA2802023C (cg-RX-API-DMAC7.html)
CY (1) CY1119704T1 (cg-RX-API-DMAC7.html)
DK (1) DK2580226T3 (cg-RX-API-DMAC7.html)
ES (1) ES2654156T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20171947T1 (cg-RX-API-DMAC7.html)
HU (1) HUE035187T2 (cg-RX-API-DMAC7.html)
IL (1) IL223570A (cg-RX-API-DMAC7.html)
LT (1) LT2580226T (cg-RX-API-DMAC7.html)
MX (1) MX342946B (cg-RX-API-DMAC7.html)
NO (1) NO2580226T3 (cg-RX-API-DMAC7.html)
PL (1) PL2580226T3 (cg-RX-API-DMAC7.html)
PT (1) PT2580226T (cg-RX-API-DMAC7.html)
RS (1) RS56690B1 (cg-RX-API-DMAC7.html)
RU (1) RU2595717C2 (cg-RX-API-DMAC7.html)
SI (1) SI2580226T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201700603T1 (cg-RX-API-DMAC7.html)
WO (1) WO2011155822A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201209395B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants
HRP20192113T1 (hr) 2014-07-24 2020-02-21 Litevax B.V. Adjuvanti
KR20250052985A (ko) 2023-10-11 2025-04-21 세종대학교산학협력단 삼당류의 제조방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232150A (en) * 1979-07-09 1980-11-04 American Cyanamid Company Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses
GB8703128D0 (en) * 1987-02-11 1987-03-18 Donmarn Ltd Anti-scaling compounds
US5543505A (en) * 1993-03-15 1996-08-06 Sloan-Kettering Institute For Cancer Research Synthetic compounds which bind to H. pylori, and uses thereof
US6303120B1 (en) * 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
US5708163A (en) * 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
CZ297431B6 (cs) * 1994-08-04 2006-12-13 Quadrant Holdings Cambridge Limited Prostredek obsahující dodávací systém pevné dávkypro prímou aplikaci v pevné forme a zpusob jeho výroby
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US6517860B1 (en) * 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
JP3041799B1 (ja) * 1998-09-29 2000-05-15 株式会社微生物化学研究所 新規なアジュバント及びそれを用いたワクチン
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
GB0124710D0 (en) * 2001-10-15 2001-12-05 Quadrant Healthcare Uk Ltd Therapeutic composition
ES2315777T3 (es) * 2005-12-01 2009-04-01 Wella Aktiengesellschaft Uso de poliester de di-u oligosacarido en productos para el peinado del cabello.
US9045516B2 (en) * 2007-04-16 2015-06-02 Suri Saranathan Iyer Synthetic ligands for the differentiation of closely related toxins and pathogens
WO2009140683A1 (en) * 2008-05-16 2009-11-19 Research Foundation Of The City University Of New York Living copolymer protein/peptide hybrids for biomedical applications
EP2392579B1 (en) * 2009-02-02 2016-11-23 Otsuka Chemical Co., Ltd. Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants

Also Published As

Publication number Publication date
RU2013100945A (ru) 2014-07-20
CA2802023A1 (en) 2011-12-15
PT2580226T (pt) 2018-01-05
US9327020B2 (en) 2016-05-03
RU2595717C2 (ru) 2016-08-27
EP3312188A1 (en) 2018-04-25
ZA201209395B (en) 2014-05-28
AU2011262606B2 (en) 2016-10-27
CN103154013A (zh) 2013-06-12
JP2016216471A (ja) 2016-12-22
BR112012031440A2 (pt) 2017-04-18
CY1119704T1 (el) 2018-06-27
JP6004586B2 (ja) 2016-10-12
US20130273082A1 (en) 2013-10-17
EP2580226A1 (en) 2013-04-17
CN103154013B (zh) 2017-03-15
EP2397484A1 (en) 2011-12-21
KR101929973B1 (ko) 2018-12-18
DK2580226T3 (en) 2018-01-08
IL223570A (en) 2017-03-30
PL2580226T3 (pl) 2018-05-30
KR20130056273A (ko) 2013-05-29
AU2011262606A1 (en) 2013-01-10
HUE035187T2 (hu) 2018-05-02
ES2654156T3 (es) 2018-02-12
MX342946B (es) 2016-10-18
US20170057987A1 (en) 2017-03-02
CA2802023C (en) 2020-07-14
WO2011155822A1 (en) 2011-12-15
SI2580226T1 (en) 2018-04-30
RS56690B1 (sr) 2018-03-30
NO2580226T3 (cg-RX-API-DMAC7.html) 2018-04-28
SMT201700603T1 (it) 2018-03-08
MX2012014422A (es) 2013-08-27
EP2580226B1 (en) 2017-11-29
JP2013528211A (ja) 2013-07-08
HRP20171947T1 (hr) 2018-02-23

Similar Documents

Publication Publication Date Title
IL253870A0 (en) Certain amino-pyrimidines, their assemblies, and methods of using them
IL222465A0 (en) Certain amino-pyridazines, compositions thereof, and methods for their use
EP2580993A4 (en) CHAIR
AU335087S (en) Chair
IL222520A0 (en) Ketoheteroarylpiperidine and ketoheteroarylpiperazine derivates as fungicides
ZA201207178B (en) Oxadiazole compounds,their preparation and use
EP2599490A4 (en) COMPOSITION FOR TREATMENT OF INJURY, FORMULATION AND USE THEREOF
IL223405B (en) Phosphoplatins, preparations containing them and their uses
AU332656S (en) Chair
IL225724A (en) History of acylbenzene, its salts and their uses
ZA201209395B (en) Trisaccharide derivates,and their use as adjuvants
PT2603217E (pt) Novos derivados 6,7-dissubstituídos de isoquinolina e sua utilização
EP2621490A4 (en) PROPARGYL-TRIFLUOROMETHOXY-AMINO-BENZOTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF
PL2364616T3 (pl) Krzesło
AU332276S (en) Low chair
GB201017070D0 (en) My chair
GB201010608D0 (en) Compounds, compositions and use
AU337142S (en) Chair
PH32010000762S1 (en) Chair
PH32010000028S1 (en) Chair
PH32010000029S1 (en) Chair
PH32010000362S1 (en) Chair
PH32010000761S1 (en) Chair
TWM385285U (en) Chair
AU331861S (en) Chair